(+)-catechin multiple interactions ISO RGD:1348013 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of HMGA2 mRNA CTD PMID:24763279 (-)-demecolcine decreases expression ISO RGD:1348013 6480464 Demecolcine results in decreased expression of HMGA2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate decreases expression ISO RGD:1348013 6480464 epigallocatechin gallate results in decreased expression of HMGA2 protein CTD PMID:31195006 1,2-dimethylhydrazine decreases expression ISO RGD:1552855 6480464 1, 2-Dimethylhydrazine results in decreased expression of HMGA2 mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:1348013 6480464 1-nitropyrene results in increased expression of HMGA2 mRNA CTD PMID:19041380 17beta-estradiol multiple interactions ISO RGD:1552855 6480464 ESR1 protein promotes the reaction [Estradiol results in decreased expression of HMGA2 mRNA] CTD PMID:25210133 17beta-estradiol multiple interactions ISO RGD:1348013 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of HMGA2 mRNA CTD PMID:30165855 17beta-estradiol decreases expression ISO RGD:1552855 6480464 Estradiol results in decreased expression of HMGA2 mRNA CTD PMID:25210133 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552855 6480464 Tetrachlorodibenzodioxin results in increased expression of HMGA2 mRNA CTD PMID:19770486 , PMID:27562557 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HMGA2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of HMGA2 mRNA CTD PMID:32109520 2,4-diaminotoluene increases expression ISO RGD:1552855 6480464 2, 4-diaminotoluene results in increased expression of HMGA2 mRNA CTD PMID:20713471 2-deoxy-D-glucose multiple interactions ISO RGD:1348013 6480464 Deoxyglucose inhibits the reaction [HMGA2 protein results in decreased expression of COX4 protein] more ... CTD PMID:34481905 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of HMGA2 mRNA CTD PMID:22008535 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:1552855 6480464 tetrabromobisphenol A results in increased expression of HMGA2 mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HMGA2 mRNA more ... CTD PMID:28628672 3-methyladenine multiple interactions ISO RGD:1348013 6480464 3-methyladenine inhibits the reaction [HMGA2 protein results in decreased expression of COX4 protein], 3-methyladenine inhibits the reaction [HMGA2 protein results in decreased expression of ND1 protein] CTD PMID:34481905 3-methylcholanthrene increases expression ISO RGD:1552855 6480464 Methylcholanthrene results in increased expression of HMGA2 mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1552855 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of HMGA2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HMGA2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1348013 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of HMGA2 protein CTD PMID:31945527 , PMID:34186270 4-hydroxynon-2-enal increases expression ISO RGD:1552855 6480464 4-hydroxy-2-nonenal results in increased expression of HMGA2 mRNA CTD PMID:19191707 4-nitrophenol decreases expression ISO RGD:1552855 6480464 4-nitrophenol results in decreased expression of HMGA2 mRNA CTD PMID:34673133 4-phenylbutyric acid multiple interactions ISO RGD:1348013 6480464 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HMGA2 protein] CTD PMID:36473502 4-phenylbutyric acid decreases expression ISO RGD:1348013 6480464 4-phenylbutyric acid results in decreased expression of HMGA2 protein CTD PMID:36473502 5-azacytidine increases expression ISO RGD:1348013 6480464 Azacitidine results in increased expression of HMGA2 mRNA CTD PMID:21245298 5-azacytidine multiple interactions ISO RGD:1348013 6480464 TP73 protein promotes the reaction [Azacitidine results in increased expression of HMGA2 mRNA] CTD PMID:21245298 acrylamide decreases expression ISO RGD:1348013 6480464 Acrylamide results in decreased expression of HMGA2 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO RGD:1552855 6480464 Aflatoxin B1 results in increased expression of HMGA2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1348013 6480464 Aflatoxin B1 results in decreased methylation of HMGA2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1348013 6480464 Aflatoxin B1 results in increased expression of HMGA2 mRNA CTD PMID:22100608 aflatoxin M1 decreases expression ISO RGD:1348013 6480464 Aflatoxin M1 results in decreased expression of HMGA2 mRNA CTD PMID:30928695 aldehydo-D-glucose increases expression ISO RGD:1552855 6480464 Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO RGD:1552855 6480464 Tretinoin results in decreased expression of HMGA2 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:1348013 6480464 Tretinoin results in decreased expression of HMGA2 mRNA CTD PMID:33167477 antimycin A increases expression ISO RGD:1348013 6480464 Antimycin A results in increased expression of HMGA2 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:1348013 6480464 aristolochic acid I results in decreased expression of HMGA2 mRNA CTD PMID:33212167 arsane affects methylation ISO RGD:1348013 6480464 Arsenic affects the methylation of HMGA2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1348013 6480464 Arsenic affects the methylation of HMGA2 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of HMGA2 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:1552855 6480464 Benzo(a)pyrene results in decreased expression of HMGA2 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:1348013 6480464 Benzo(a)pyrene affects the methylation of HMGA2 3' UTR, Benzo(a)pyrene affects the methylation of HMGA2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1348013 6480464 Benzo(a)pyrene results in decreased expression of HMGA2 mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1348013 6480464 7 more ... CTD PMID:20382639 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HMGA2 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1552855 6480464 bisphenol A results in increased expression of HMGA2 mRNA CTD PMID:35479511 bisphenol A decreases expression ISO RGD:1348013 6480464 bisphenol A results in decreased expression of HMGA2 mRNA CTD PMID:29275510 , PMID:33670352 bisphenol A affects expression ISO RGD:1348013 6480464 bisphenol A affects the expression of HMGA2 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of HMGA2 gene CTD PMID:28505145 bisphenol A affects methylation ISO RGD:1552855 6480464 bisphenol A affects the methylation of HMGA2 promoter CTD PMID:27334623 bisphenol A multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of HMGA2 mRNA CTD PMID:28628672 bisphenol A decreases methylation ISO RGD:1552855 6480464 bisphenol A results in decreased methylation of HMGA2 promoter CTD PMID:27312807 Bisphenol B increases expression ISO RGD:1348013 6480464 bisphenol B results in increased expression of HMGA2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of HMGA2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1348013 6480464 bisphenol F results in increased expression of HMGA2 protein CTD PMID:34186270 butanal increases expression ISO RGD:1348013 6480464 butyraldehyde results in increased expression of HMGA2 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1348013 6480464 Cadmium results in increased expression of HMGA2 mRNA, Cadmium results in increased expression of HMGA2 protein CTD PMID:27071802 cadmium atom multiple interactions ISO RGD:1552855 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMGA2 protein CTD PMID:34481905 cadmium atom multiple interactions ISO RGD:1348013 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMGA2 protein more ... CTD PMID:27071802 , PMID:34481905 cadmium dichloride increases expression ISO RGD:1348013 6480464 Cadmium Chloride results in increased expression of HMGA2 protein CTD PMID:28830677 cadmium dichloride multiple interactions ISO RGD:1552855 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMGA2 protein CTD PMID:34481905 cadmium dichloride increases expression ISO RGD:1552855 6480464 Cadmium Chloride results in increased expression of HMGA2 protein CTD PMID:28830677 cadmium dichloride multiple interactions ISO RGD:1348013 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of HMGA2 protein more ... CTD PMID:28830677 , PMID:34481905 cadmium sulfate decreases expression ISO RGD:1348013 6480464 cadmium sulfate results in decreased expression of HMGA2 mRNA CTD PMID:12064557 caffeine decreases expression ISO RGD:1348013 6480464 Caffeine results in decreased expression of HMGA2 protein CTD PMID:31195006 caffeine decreases phosphorylation ISO RGD:1348013 6480464 Caffeine results in decreased phosphorylation of HMGA2 protein CTD PMID:35688186 cannabidiol decreases expression ISO RGD:1348013 6480464 Cannabidiol results in decreased expression of HMGA2 mRNA CTD PMID:27918106 choline multiple interactions ISO RGD:1552855 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HMGA2 gene CTD PMID:20938992 chromium(6+) multiple interactions ISO RGD:1348013 6480464 HMGA2 protein promotes the reaction [chromium hexavalent ion results in increased expression of PINK1 protein], HMGA2 protein promotes the reaction [chromium hexavalent ion results in increased expression of PRKN protein] CTD PMID:32866567 chromium(6+) increases expression ISO RGD:1348013 6480464 chromium hexavalent ion results in increased expression of HMGA2 protein CTD PMID:32866567 ciguatoxin CTX1B affects expression ISO RGD:1552855 6480464 Ciguatoxins affects the expression of HMGA2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:1552855 6480464 Cisplatin results in increased expression of HMGA2 mRNA CTD PMID:21151649 cisplatin decreases expression ISO RGD:1348013 6480464 Cisplatin results in decreased expression of HMGA2 mRNA CTD PMID:19561079 cisplatin multiple interactions ISO RGD:1348013 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of HMGA2 mRNA CTD PMID:21858171 cobalt dichloride decreases expression ISO RGD:1348013 6480464 cobaltous chloride results in decreased expression of HMGA2 mRNA CTD PMID:19320972 , PMID:19376846 copper(II) sulfate decreases expression ISO RGD:1348013 6480464 Copper Sulfate results in decreased expression of HMGA2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1348013 6480464 Asbestos, Crocidolite results in increased expression of HMGA2 mRNA CTD PMID:18687144 crotonaldehyde decreases expression ISO RGD:1348013 6480464 2-butenal results in decreased expression of HMGA2 mRNA CTD PMID:20471460 cyclosporin A increases expression ISO RGD:1552855 6480464 Cyclosporine results in increased expression of HMGA2 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1348013 6480464 Cyclosporine results in decreased expression of HMGA2 mRNA CTD PMID:25562108 D-glucose increases expression ISO RGD:1552855 6480464 Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of HMGA2 mRNA CTD PMID:23914054 deguelin increases expression ISO RGD:1348013 6480464 deguelin results in increased expression of HMGA2 mRNA CTD PMID:33512557 dexamethasone multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HMGA2 mRNA more ... CTD PMID:28628672 dioxygen decreases expression ISO RGD:1348013 6480464 Oxygen deficiency results in decreased expression of HMGA2 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:1552855 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of HMGA2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1348013 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:1348013 6480464 HMGA2 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression ISO RGD:1348013 6480464 Doxorubicin results in decreased expression of HMGA2 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of HMGA2 mRNA CTD PMID:29391264 ethyl methanesulfonate decreases expression ISO RGD:1348013 6480464 Ethyl Methanesulfonate results in decreased expression of HMGA2 mRNA CTD PMID:23649840 etoposide affects response to substance ISO RGD:1348013 6480464 HMGA2 protein affects the susceptibility to Etoposide CTD PMID:16217747 fluoranthene multiple interactions ISO RGD:1552855 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA] CTD PMID:28329830 folic acid multiple interactions ISO RGD:1552855 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HMGA2 gene CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1348013 6480464 Formaldehyde results in decreased expression of HMGA2 mRNA CTD PMID:23649840 , PMID:28937961 genistein decreases expression ISO RGD:1348013 6480464 Genistein results in decreased expression of HMGA2 mRNA CTD PMID:22228119 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of HMGA2 mRNA CTD PMID:22061828 , PMID:33387578 glucose increases expression ISO RGD:1552855 6480464 Glucose results in increased expression of HMGA2 mRNA CTD PMID:17178593 hypochlorous acid increases expression ISO RGD:1552855 6480464 Hypochlorous Acid results in increased expression of HMGA2 mRNA CTD PMID:19376150 indometacin multiple interactions ISO RGD:1348013 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HMGA2 mRNA more ... CTD PMID:28628672 ivermectin decreases expression ISO RGD:1348013 6480464 Ivermectin results in decreased expression of HMGA2 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1552855 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of HMGA2 gene CTD PMID:20938992 lead(0) affects expression ISO RGD:1348013 6480464 Lead affects the expression of HMGA2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1348013 6480464 Lead affects the expression of HMGA2 mRNA CTD PMID:28903495 maneb multiple interactions ISO RGD:1552855 6480464 [Paraquat co-treated with Maneb] results in decreased expression of HMGA2 mRNA CTD PMID:18386188 melphalan decreases expression ISO RGD:1348013 6480464 Melphalan results in decreased expression of HMGA2 mRNA CTD PMID:22363485 methyl methanesulfonate decreases expression ISO RGD:1348013 6480464 Methyl Methanesulfonate results in decreased expression of HMGA2 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1348013 6480464 methylmercuric chloride results in increased expression of HMGA2 mRNA CTD PMID:23179753 methylparaben decreases expression ISO RGD:1348013 6480464 methylparaben results in decreased expression of HMGA2 mRNA CTD PMID:31745603 mitomycin C affects response to substance ISO RGD:1348013 6480464 HMGA2 protein affects the susceptibility to Mitomycin CTD PMID:16217747 Monobutylphthalate affects expression ISO RGD:1552855 6480464 monobutyl phthalate affects the expression of HMGA2 mRNA CTD PMID:19162170 N-acetyl-L-cysteine multiple interactions ISO RGD:1348013 6480464 Acetylcysteine inhibits the reaction [Cadmium results in increased expression of HMGA2 protein] CTD PMID:27071802 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1348013 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of HMGA2 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of HMGA2 mRNA CTD PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:1348013 6480464 Diethylnitrosamine results in increased expression of HMGA2 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions ISO RGD:1552855 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of HMGA2 mRNA] CTD PMID:17854601 N-nitrosodiethylamine increases expression ISO RGD:1552855 6480464 Diethylnitrosamine results in increased expression of HMGA2 mRNA CTD PMID:17854601 paracetamol increases expression ISO RGD:1348013 6480464 Acetaminophen results in increased expression of HMGA2 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HMGA2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:1552855 6480464 [Paraquat co-treated with Maneb] results in decreased expression of HMGA2 mRNA CTD PMID:18386188 pentanal increases expression ISO RGD:1348013 6480464 pentanal results in increased expression of HMGA2 mRNA CTD PMID:26079696 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of HMGA2 mRNA CTD PMID:19162173 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HMGA2 mRNA CTD PMID:19162173 piroxicam multiple interactions ISO RGD:1348013 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of HMGA2 mRNA CTD PMID:21858171 potassium dichromate decreases expression ISO RGD:1552855 6480464 Potassium Dichromate results in decreased expression of HMGA2 mRNA CTD PMID:23608068 potassium dichromate increases expression ISO RGD:1348013 6480464 Potassium Dichromate results in increased expression of HMGA2 protein CTD PMID:36473502 potassium dichromate increases expression ISO RGD:1552855 6480464 Potassium Dichromate results in increased expression of HMGA2 protein CTD PMID:36473502 potassium dichromate multiple interactions ISO RGD:1348013 6480464 4-phenylbutyric acid inhibits the reaction [Potassium Dichromate results in increased expression of HMGA2 protein], Potassium Dichromate promotes the reaction [HMGA2 protein binds to ATF4 promoter] CTD PMID:36473502 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of HMGA2 mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:1552855 6480464 NCOA2 protein affects the reaction [Progesterone results in decreased expression of HMGA2 mRNA] CTD PMID:17556502 progesterone decreases expression ISO RGD:1552855 6480464 Progesterone results in decreased expression of HMGA2 mRNA CTD PMID:17556502 quercitrin increases expression ISO RGD:1348013 6480464 quercitrin results in increased expression of HMGA2 mRNA CTD PMID:25193878 raloxifene affects expression ISO RGD:1348013 6480464 Raloxifene Hydrochloride affects the expression of HMGA2 mRNA CTD PMID:14699072 resveratrol decreases expression ISO RGD:1552855 6480464 resveratrol results in decreased expression of HMGA2 protein CTD PMID:25505154 rotenone decreases expression ISO RGD:1348013 6480464 Rotenone results in decreased expression of HMGA2 mRNA CTD PMID:33512557 SB 203580 multiple interactions ISO RGD:1552855 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of HMGA2 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:1348013 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos increases expression ISO RGD:1552855 6480464 Asbestos, Serpentine results in increased expression of HMGA2 mRNA CTD PMID:23917077 silicon dioxide increases expression ISO RGD:1348013 6480464 Silicon Dioxide analog results in increased expression of HMGA2 mRNA, Silicon Dioxide results in increased expression of HMGA2 mRNA CTD PMID:25351596 , PMID:25895662 silicon dioxide increases expression ISO RGD:1552855 6480464 Silicon Dioxide results in increased expression of HMGA2 mRNA CTD PMID:19073995 sodium arsenite affects methylation ISO RGD:1348013 6480464 sodium arsenite affects the methylation of HMGA2 gene CTD PMID:28589171 sulforaphane increases expression ISO RGD:1348013 6480464 sulforaphane results in increased expression of HMGA2 mRNA CTD PMID:31838189 sunitinib decreases expression ISO RGD:1348013 6480464 Sunitinib results in decreased expression of HMGA2 mRNA CTD PMID:31533062 tebufenpyrad increases expression ISO RGD:1348013 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of HMGA2 mRNA CTD PMID:33512557 tert-butyl hydroperoxide increases expression ISO RGD:1552855 6480464 tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA CTD PMID:14729362 tetrachloromethane increases expression ISO RGD:1552855 6480464 Carbon Tetrachloride results in increased expression of HMGA2 mRNA CTD PMID:27339419 , PMID:31919559 topotecan affects response to substance ISO RGD:1348013 6480464 HMGA2 protein affects the susceptibility to Topotecan CTD PMID:16217747 trichostatin A increases expression ISO RGD:1348013 6480464 trichostatin A results in increased expression of HMGA2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1348013 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMGA2 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1348013 6480464 Triclosan results in decreased expression of HMGA2 mRNA CTD PMID:30510588 triptonide decreases expression ISO RGD:1552855 6480464 triptonide results in decreased expression of HMGA2 mRNA CTD PMID:33045310 trovafloxacin increases expression ISO RGD:1552855 6480464 trovafloxacin results in increased expression of HMGA2 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:1348013 6480464 Tunicamycin results in increased expression of HMGA2 protein CTD PMID:36473502 urethane decreases expression ISO RGD:1348013 6480464 Urethane results in decreased expression of HMGA2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1552855 6480464 Valproic Acid results in decreased expression of HMGA2 mRNA CTD PMID:19136453 , PMID:20546886 valproic acid decreases expression ISO RGD:1348013 6480464 Valproic Acid results in decreased expression of HMGA2 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid affects expression ISO RGD:1348013 6480464 Valproic Acid affects the expression of HMGA2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1552855 6480464 Valproic Acid results in increased expression of HMGA2 mRNA CTD PMID:24896083 valproic acid increases expression ISO RGD:1348013 6480464 Valproic Acid results in increased expression of HMGA2 mRNA CTD PMID:23179753 , PMID:26272509 valproic acid multiple interactions ISO RGD:1348013 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of HMGA2 mRNA CTD PMID:27188386 vincristine decreases expression ISO RGD:1348013 6480464 Vincristine results in decreased expression of HMGA2 mRNA CTD PMID:23649840
